Product Images Drospirenone And Ethinyl Estradiol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Drospirenone And Ethinyl Estradiol NDC 0378-7299 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: VTE Risk with Yasmin Relative to LNG-Containing COCs (adjusted risk#) - c1d93dd5 2230 419d 9dbd f0ae72df40bc 01

Figure 1: VTE Risk with Yasmin Relative to LNG-Containing COCs (adjusted risk#) - c1d93dd5 2230 419d 9dbd f0ae72df40bc 01

This text contains the names of various studies and their associated hazard or odds ratios. It is not possible to provide a useful description without further information about the studies or their topic.*

Figure 2: Likelihood of Developing a VTE - c1d93dd5 2230 419d 9dbd f0ae72df40bc 02

Figure 2: Likelihood of Developing a VTE - c1d93dd5 2230 419d 9dbd f0ae72df40bc 02

This is a chart showing non-pregnant and postpartum ranges for non-users and COC users, respectively. The chart also includes the number of women out of 10,000 Women Years (W) who experienced a blood clot. Some of the text is unclear.*

Structural Formula - c1d93dd5 2230 419d 9dbd f0ae72df40bc 03

Structural Formula - c1d93dd5 2230 419d 9dbd f0ae72df40bc 03

Drospirenone Ethinyl estradiol is a combined hormonal contraceptive pill containing progestin drospirenone and estrogen ethinyl estradiol. It works by preventing ovulation, thickening cervical mucus to prevent sperm from reaching the egg, and thinning the uterus lining to prevent implantation of a fertilized egg. It is used to prevent pregnancy and may also be used to treat acne and premenstrual dysphoric disorder.*

BLISTER - c1d93dd5 2230 419d 9dbd f0ae72df40bc 04

BLISTER - c1d93dd5 2230 419d 9dbd f0ae72df40bc 04

Chart - c1d93dd5 2230 419d 9dbd f0ae72df40bc 05

Chart - c1d93dd5 2230 419d 9dbd f0ae72df40bc 05

This text provides information on the ranges of blood clot incidents in non-pregnant individuals, both COC users and non-users, as well as postpartum ranges for up to 12 weeks. It then highlights the number of women with a blood clot out of 10,000 women years (W), with pregnancy data based on actual duration in reference studies.*

image 01

image 01

This is a product description for Black iR R only Drospirenone and Ethinyl Estradiol Tablets which is used as an oral contraceptive to prevent pregnancy. It is not effective against sexually transmitted diseases including HIV infection. The package contains 3 pouches, each having one blister pack of 28 tablets. The dosage involves taking one yellow tablet daily for 24 consecutive days followed by one green inert tablet for 4 consecutive days. The tablets contain 3 mg drospirenone and 0.02 mg ethinyl estradiol. The product is manufactured by Mylan Pharmaceuticals, is made in India, and is intended for use as per the prescribed schedule. More information about the prescribing notes can be found in the accompanying package insert. The product label also contains information to be passed on to the customer. The product is colored with FD&C Yellow No. 5 (tartrazine) and should be stored at 20 to 25°C (68° to 77°F). It is the dispenser's responsibility to provide the customer with the combined detailed and brief patient labeling along with the carrier sleeve that comes with the product. The text also has a few non-English characters but they are not used in the description.*

image 02

image 02

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.